Cascadian Therapeutics to Present at Cowen and Company 37th Annual Health Care Conference Feb 27, 2017 09:00AM
Cascadian Therapeutics (CASC) Prices 23.2M Shares at $3.30, and Preferred Stock Jan 24, 2017 08:51AM
Cascadian Therapeutics Prices $82.5 Million Concurrent Offerings of Common Stock and Preferred Stock Jan 24, 2017 08:50AM
Cascadian Therapeutics (CASC) Plans Public Offerings of Common Stock and Preferred Stock Jan 23, 2017 04:03PM
Cascadian Therapeutics Announces Proposed Concurrent Public Offerings of Common Stock and Preferred Stock Jan 23, 2017 04:01PM


Jun 28, 2016 04:01PM Cascadian Therapeutics Announces Exercise of Underwriters' Over-Allotment Option and Closing of $46.0 million Concurrent Offerings of Common Stock and Series D Convertible Preferred Stock
Jun 23, 2016 09:21AM Cascadian Therapeutics (CASC) Prices 35M Shares at $0.80/Share, Concurrent Series D Convertible Preferred Stock Offering
Jun 23, 2016 09:20AM Cascadian Therapeutics Prices $41.8 Million Concurrent Offerings of Common Stock and Series D Convertible Preferred Stock
Jun 22, 2016 04:01PM Cascadian Therapeutics (CASC) to Offer Common Stock
Jun 22, 2016 04:01PM Cascadian Therapeutics Announces Proposed Public Offering